4//SEC Filing
TURKEL CATHERINE C. 4
Accession 0000899243-18-007642
CIK 0001404281other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 6:46 PM ET
Size
7.6 KB
Accession
0000899243-18-007642
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Chief Development Officer
Transactions
- Award
Common Stock
2018-03-13+20,000→ 44,519 total - Award
Stock Option (Right to Buy)
2018-03-13+24,000→ 24,000 totalExercise: $4.83Exp: 2028-03-13→ Common Stock (24,000 underlying)
Footnotes (2)
- [F1]This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date.
- [F2]This option represents a right to purchase a total of 24,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 13, 2019, with the remaining 18,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001705278
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 6:46 PM ET
- Size
- 7.6 KB